Gradient Corporation

In October 2008, an expert scientific panel, convened by Gradient Corporation, published the results of its weight-of-the-evidence evaluation of low-dose reproductive and developmental effects of BPA. Based on its review of scientific literature available through July 2008, the panel concluded: "The weight of evidence does not support the hypothesis that low oral doses of BPA adversely affect human reproductive and developmental health." This evaluation is the third in a series that began with an evaluation, published in 2004, by an independent panel of scientific experts organized by the Harvard Center for Risk Analysis. To view a summary, please click here. To view the full report, please click here.